Skip to main content

Advanced Glycation End-Products Market in US Driven by High Incidence of Alzheimer's Disease

 


Advanced glycation end-product is a sugar metabolite formed by excessive accumulation of sugar in the cells and is commonly termed as glycation. The excessive formation of sugars in cells leads to the destruction of the cell membranes leading to accumulation of intracellular adenosine triphosphate (ICTP) that eventually phosphates the adenosine in the cell. Glycation can occur in several tissues and is characterized by the generation of excessive quantities of the glycosaminoglycan that results in the abnormal accumulation of sugars in the cells.

High incidence of diabetes contributes to growth of advanced glycation end-products market. The formation of advanced glycation end products appears to be enhanced in the diabetes as a result of hyperglycemia. According to the National Diabetes and Diabetic Retinopathy Survey report published in October 2019, the prevalence of diabetes in India was 11.8% during 2015-2019 and the prevalence of known diabetes cases was 8.0% and new diabetes cases was 3.8% during the period.

Advanced glycation end-product are proteins or lipids that become glycated as a result of exposure to sugars. They are often a pre-cancer marker implicated in the development or worsening of several degenerative illnesses, including Alzheimer's, diabetes, and atherosclerosis. The incidence of Alzheimer's disease and diabetes is high in the U.S., which indicates growth of the advanced glycation end-products market in North America.  According to Alzheimer’s Association, around 5.8 million people in the U.S. aged 65 and older are living with Alzheimer's dementia in 2020.

Several studies have linked high consumption of advanced glycation end-product with wheezing symptoms in children. Modern diets are linked to high levels of advanced glycation end-products. Cooking methods that increase intake of advanced glycation end-products include barbecuing, grilling, roasting, baking, frying, sautéing, broiling, searing, and toasting. High levels of these products are associated with the majority of chronic diseases, which may hinder growth of the advanced glycation end-products market.  

Dietary advanced glycation end products are known to contribute to increased oxidant stress and inflammation. The interaction between advanced glycation end-product and the receptor for advanced glycation end-product is thought to ultimately lead to oxidative stress. Formation of advanced glycation end-products also induces production of reactive oxygen species, which contribute to oxidative stress. Such scenario is also expected to hinder growth of the advanced glycation end-products market.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...
Post a Comment
Read more

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  
Post a Comment
Read more

Immuno-oncology: Combination Therapies and Emerging Targets

  The study of and creation of therapies that use the immune system of the body to combat cancer are known as immuno-oncology. Our immune system, which is made up of a complex web of organs, cells, and molecules, guards us against external invaders like bacteria, fungus, and viruses that might infect us. The immune system is capable of locating and eliminating foreign objects as well as attacking aberrant cells. The immune system has the best chance of specifically destroying tumours without harming healthy tissue and having long-term memory that can stop cancer from coming back. The development of tumours can be permanently prevented or managed by a mechanism known as immunosurveillance, according to research in immuno-oncology conducted over the past 30 years. Recognition of tumour antigens is what gives the immune response its tumour specificity. The most well-established therapeutic class of IO drugs to date, immune checkpoint inhibitors have demonstrated significant effic...
Post a Comment
Read more